Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Understand what makes a retirement plan good. Evaluate essential elements for a successful retirement strategy.
20,725 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Tesla faces a valuation crossroads as AI-driven growth challenges traditional EV metrics. The stock trades near $412 ...
Investors are using margin loans to amplify gains, but rising leverage could trigger sharp moves. The latest margin d...
Applied Optoelectronics and Lumentum surged as Texas expansion plans lift demand for AI optics components, boosting r...
Investors weighing Dow and LYB face a crossroads in 2026. This guide breaks down business models, catalysts, risks, a...
A routine call turned into a financial nightmare when a fraudster impersonated Chase Bank, guiding a victim to transf...
Strategy's Phong Le anchors the firm's crypto stance to a debt-risk threshold at $8K–$10K, underscoring balance-sheet...
A trio of tech giants is sending a quiet, powerful message about AI infrastructure spending. SpaceX, Alphabet, and SK...
SpaceX shares have tumbled from their peak, trading around $125 as of mid-July 2026. Analysts debate whether the retr...
Apple may be eyeing a breakthrough to reduce on-device memory needs, a move that could shake Micron and the broader m...
Mark Cuban is reviving the debate over wage inequality by urging companies to grant stock to every worker. His pitch ...
When a major AI breach hit, Hugging Face found a fast, practical path by running a Chinese model locally. This decisi...